Lifitegrast 59651-0450
Product NDC
59651-0450- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- For Solution
- Route
- Ophthalmic
- Product Type
- Human Prescription Drug
- Marketing Start
- November 7, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA215063
Need to source Lifitegrast? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lifitegrast | 50 mg/mL |
Drug Class
Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]
Packaging Options(1)
60 POUCH in 1 CARTON (59651-450-60) / 5 AMPULE in 1 POUCH (59651-450-05) / .2 mL in 1 AMPULE